Lennox-Gastaut Syndrome SIG

 

Leadership:

Jacqueline Gofshteyn jag9194@med.cornell.edu

 

SIG Objectives:

  • Promote patient-oriented research that specifically targets improving the diagnosis, prevention, treatment, and management of children with Lennox Gastaut Syndrome
  • Improve seizure, cognitive, behavioral and functional outcomes for children with LGS through collaborative research.

 

Current Projects and Collaborations:

  • Tonic seizures as a biomarker for LGS
  • Developing an LGS functional outcome measure to track therapeutic response

 

Plans for Future Projects:

  • Expansion of biomarker development to multisite studies

 

Members (updated every 6 months, names +/- emails):

Anup.patel@nationwidechildrens.org; dave.clarke@austin.utexas.edu; DiGiovineM@email.chop.edu; Jorge.Vidaurre@nationwidechildrens.org; Jules Beal <jcb9023@med.cornell.edu>; karen.skjei@louisville.edu; MZupanc@choc.org; Sabiha Merchant <sam9048@med.cornell.edu>; shussain@mednet.ucla.edu; scott.demarest@childrenscolorado.org; Srishti Nangia <srn9001@med.cornell.edu>; TVU@childrensnational.org; Zachary Grinspan <zag9005@med.cornell.edu>; suchetaj@med.umich.edu; vdanan2019@health.fau.edu; Tracy Dixon-Salazar <tracy@lgsfoundation.org>; DCabacar@childrensnational.org

 

Upcoming meetings:

Monthly, next 1/12/21 12 pm EST